JAVIER
FERNANDEZ FERNANDEZ
Profesor Ayudante Doctor
King's College London
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de King's College London (11)
2024
-
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 7, pp. 877-888
2023
2022
-
Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates
Liver International, Vol. 42, Núm. 2, pp. 435-443
2021
2020
-
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
Journal of Hepatology, Vol. 72, Núm. 4, pp. 688-701
-
Correction to ‘Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF’ [J Hepatol 2020 (72) 688–701] (Journal of Hepatology (2020) 72(4) (688–701), (S0168827819306968), (10.1016/j.jhep.2019.11.009))
Journal of Hepatology
-
Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival
Hepatology, Vol. 71, Núm. 4, pp. 1381-1390
2019
-
Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF
JHEP Reports, Vol. 1, Núm. 3, pp. 179-187
2016
-
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure
Hepatology, Vol. 64, Núm. 4, pp. 1249-1264
2015
-
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure
Journal of Hepatology, Vol. 62, Núm. 4, pp. 831-840